{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:55:36Z","timestamp":1770634536610,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,31]]},"DOI":"10.7759\/cureus.17598","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T13:40:49Z","timestamp":1630417249000},"source":"Crossref","is-referenced-by-count":2,"title":["An Aggressive Presentation of Mantle Cell Lymphoma With Unique Molecular Features"],"prefix":"10.7759","author":[{"given":"Arati A","family":"Inamdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagy","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22367","article-title":"Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and national SEER areas","volume":"8","author":"Fu S","year":"2017","unstructured":"Fu S, Wang M, Lairson DR, Li R, Zhao B, Du XL. Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and national SEER areas. Oncotarget. 2017, 8:112516-29. 10.18632\/oncotarget.22367","journal-title":"Oncotarget"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8961","article-title":"Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents","volume":"7","author":"Inamdar AA","year":"2016","unstructured":"Inamdar AA, Goy A, Ayoub NM, et al.. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Oncotarget. 2016, 7:48692-731. 10.18632\/oncotarget.8961","journal-title":"Oncotarget"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07124.x","article-title":"Advances in the understanding of mantle cell lymphoma","volume":"142","author":"Jares P","year":"2008","unstructured":"Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Haematol. 2008, 142:149-65. 10.1111\/j.1365-2141.2008.07124.x","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.514968","article-title":"SOX11 expression in mantle cell lymphoma","volume":"51","author":"Xu W","year":"2010","unstructured":"Xu W, Li JY. SOX11 expression in mantle cell lymphoma. Leuk Lymphoma. 2010, 51:1962-7. 10.3109\/10428194.2010.514968","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-018-0022-5","article-title":"Genomic landscape and prognostic analysis of mantle cell lymphoma","volume":"25","author":"Yang P","year":"2018","unstructured":"Yang P, Zhang W, Wang J, Liu Y, An R, Jing H. Genomic landscape and prognostic analysis of mantle cell lymphoma. Cancer Gene Ther. 2018, 25:129-40. 10.1038\/s41417-018-0022-5","journal-title":"Cancer Gene Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: a clinicopathologic study of 80 cases","volume":"15","author":"Argatoff LH","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997, 15:2067-78. 10.1182\/blood.V89.6.2067","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0368-OA","article-title":"Immunophenotypic variations in mantle cell lymphoma and their impact on clinical behavior and outcome","volume":"142","author":"Aqil B","year":"2018","unstructured":"Aqil B, Triska G, Frater J, et al.. Immunophenotypic variations in mantle cell lymphoma and their impact on clinical behavior and outcome. Arch Pathol Lab Med. 2018, 142:1268-74. 10.5858\/arpa.2017-0368-OA","journal-title":"Arch Pathol Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-019-0079-0","article-title":"Accumulation of genetic and epigenetic alterations in normal cells and cancer risk","volume":"3","author":"Takeshima H","year":"2019","unstructured":"Takeshima H, Ushijima T. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. NPJ Precis Oncol. 2019, 3:7. 10.1038\/s41698-019-0079-0","journal-title":"NPJ Precis Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.26","article-title":"Lessons from next-generation sequencing analysis in hematological malignancies","volume":"3","author":"Braggio E","year":"2013","unstructured":"Braggio E, Egan JB, Fonseca R, Stewart AK. Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer J. 2013, 3:e127. 10.1038\/bcj.2013.26","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-838136","article-title":"A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome","volume":"132","author":"Clot G","year":"2018","unstructured":"Clot G, Jares P, Gin\u00e9 E, et al.. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. Blood. 2018, 132:413-22. 10.1182\/blood-2018-03-838136","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10716","article-title":"Gene mutations and actionable genetic lesions in mantle cell lymphoma","volume":"7","author":"Ahmed M","year":"2016","unstructured":"Ahmed M, Zhang L, Nomie K, Lam L, Wang M. Gene mutations and actionable genetic lesions in mantle cell lymphoma. Oncotarget. 2016, 7:58638-48. 10.18632\/oncotarget.10716","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Camacho E","year":"2002","unstructured":"Camacho E, Hern\u00e1ndez L, Hern\u00e1ndez S, et al.. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood. 2002, 99:238-44. 10.1182\/blood.v99.1.238","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.050400997","article-title":"Mantle cell lymphoma is characterized by inactivation of the ATM gene","volume":"97","author":"Schaffner C","year":"2000","unstructured":"Schaffner C, Idler I, Stilgenbauer S, D\u00f6hner H, Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A. 2000, 97:2773-8. 10.1073\/pnas.050400997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73932","article-title":"ATM deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium","volume":"124","author":"Moding EJ","year":"2014","unstructured":"Moding EJ, Lee CL, Castle KD, et al.. ATM deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium. J Clin Invest. 2014, 124:3325-38. 10.1172\/JCI73932","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1669","article-title":"Function and cancer genomics of FAT family genes (review)","volume":"41","author":"Katoh M","year":"2012","unstructured":"Katoh M. Function and cancer genomics of FAT family genes (review). Int J Oncol. 2012, 41:1913-8. 10.3892\/ijo.2012.1669","journal-title":"Int J Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-534271","article-title":"Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness","volume":"123","author":"Messina M","year":"2014","unstructured":"Messina M, Del Giudice I, Khiabanian H, et al.. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. Blood. 2014, 123:2378-88. 10.1182\/blood-2013-10-534271","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1179\/1607845413Y.0000000080","article-title":"Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia","volume":"18","author":"Ardjmand A","year":"2013","unstructured":"Ardjmand A, de Bock CE, Shahrokhi S, Lincz LF, Boyd AW, Burns GF, Thorne RF. Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia. Hematology. 2013, 18:315-22. 10.1179\/1607845413Y.0000000080","journal-title":"Hematology"},{"key":"ref18","unstructured":"COSMIC. catalog of somatic mutation in cancer. (2021). Accessed: July 15, 2021: https:\/\/cancer.sanger.ac.uk\/cosmic."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.12.40","article-title":"P53 mutations and cancer: a tight linkage","volume":"4","author":"Perri F","year":"2016","unstructured":"Perri F, Pisconti S, Della Vittoria Scarpati G. P53 mutations and cancer: a tight linkage. Ann Transl Med. 2016, 4:522. 10.21037\/atm.2016.12.40","journal-title":"Ann Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau DA","year":"2015","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN, et al.. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015, 526:525-30. 10.1038\/nature15395","journal-title":"Nature"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65148-an-aggressive-presentation-of-mantle-cell-lymphoma-with-unique-molecular-features","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:46Z","timestamp":1707506926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65148-an-aggressive-presentation-of-mantle-cell-lymphoma-with-unique-molecular-features"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.17598","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}